{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:25:16Z","timestamp":1791066316796,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T00:00:00Z","timestamp":1263340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1744-859x-9-3","type":"journal-article","created":{"date-parts":[[2010,1,14]],"date-time":"2010-01-14T07:14:34Z","timestamp":1263453274000},"source":"Crossref","is-referenced-by-count":6,"title":["Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'"],"prefix":"10.1186","volume":"9","author":[{"given":"Konstantinos N","family":"Fountoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,13]]},"reference":[{"issue":"2","key":"1005_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pharmthera.2007.02.003","volume":"114","author":"CA McClung","year":"2007","unstructured":"McClung CA: Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther. 2007, 114 (2): 222-232. 10.1016\/j.pharmthera.2007.02.003.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1005_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/archpsyc.1975.01760210019001","volume":"32","author":"HS Akiskal","year":"1975","unstructured":"Akiskal HS, McKinney WT: Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame. Arch Gen Psychiatry. 1975, 32 (3): 285-305.","journal-title":"Arch Gen Psychiatry"},{"issue":"2-3","key":"1005_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.psychres.2005.08.027","volume":"145","author":"P Hubain","year":"2006","unstructured":"Hubain P, Le Bon O, Vandenhende F, Van Wijnendaele R, Linkowski P: Major depression in males: effects of age, severity and adaptation on sleep variables. Psychiatry Res. 2006, 145 (2-3): 169-177. 10.1016\/j.psychres.2005.08.027.","journal-title":"Psychiatry Res"},{"issue":"1","key":"1005_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1176\/appi.psy.42.1.29","volume":"42","author":"MA Hammad","year":"2001","unstructured":"Hammad MA, Barsky AJ, Regestein QR: Correlation between somatic sensation inventory scores and hyperarousal scale scores. Psychosomatics. 2001, 42 (1): 29-34. 10.1176\/appi.psy.42.1.29.","journal-title":"Psychosomatics"},{"issue":"1-3","key":"1005_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0165-0327(02)00072-1","volume":"76","author":"D Riemann","year":"2003","unstructured":"Riemann D, Voderholzer U: Primary insomnia: a risk factor to develop depression?. J Affect Disord. 2003, 76 (1-3): 255-259. 10.1016\/S0165-0327(02)00072-1.","journal-title":"J Affect Disord"},{"issue":"8","key":"1005_CR6","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1210\/jcem.86.8.7778","volume":"86","author":"AN Vgontzas","year":"2001","unstructured":"Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP: Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001, 86 (8): 3787-3794. 10.1210\/jc.86.8.3787.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1005_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1037\/0021-843X.108.2.290","volume":"108","author":"TE Joiner Jr","year":"1999","unstructured":"Joiner TE, Steer RA, Beck AT, Schmidt NB, Rudd MD, Catanzaro SJ: Physiological hyperarousal: construct validity of a central aspect of the tripartite model of depression and anxiety. J Abnorm Psychol. 1999, 108 (2): 290-298. 10.1037\/0021-843X.108.2.290.","journal-title":"J Abnorm Psychol"},{"issue":"3","key":"1005_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0165-1781(03)00097-0","volume":"118","author":"F Fotiou","year":"2003","unstructured":"Fotiou F, Fountoulakis KN, Iacovides A, Kaprinis G: Pattern-reversed visual evoked potentials in subtypes of major depression. Psychiatry Res. 2003, 118 (3): 259-271. 10.1016\/S0165-1781(03)00097-0.","journal-title":"Psychiatry Res"},{"issue":"1","key":"1005_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1525-1381.1999.09423.x","volume":"111","author":"PW Gold","year":"1999","unstructured":"Gold PW, Chrousos GP: The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians. 1999, 111 (1): 22-34. 10.1046\/j.1525-1381.1999.09423.x.","journal-title":"Proc Assoc Am Physicians"},{"issue":"1","key":"1005_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<1::AID-DA1>3.0.CO;2-J","volume":"6","author":"CL Ehlers","year":"1997","unstructured":"Ehlers CL, Somes C, Seifritz E, Rivier JE: CRF\/NPY interactions: a potential role in sleep dysregulation in depression and anxiety. Depress Anxiety. 1997, 6 (1): 1-9. 10.1002\/(SICI)1520-6394(1997)6:1<1::AID-DA1>3.0.CO;2-J.","journal-title":"Depress Anxiety"},{"key":"1005_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1749-6632.1992.tb22846.x","volume":"658","author":"GE Bruder","year":"1992","unstructured":"Bruder GE: P300 findings for depressive and anxiety disorders. Ann N Y Acad Sci. 1992, 658: 205-222. 10.1111\/j.1749-6632.1992.tb22846.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1005_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0167-8760(92)90075-M","volume":"13","author":"C Shagass","year":"1992","unstructured":"Shagass C, Roemer RA: Evoked potential topography in major depression. II. Comparisons between subgroups. Int J Psychophysiol. 1992, 13 (3): 255-261. 10.1016\/0167-8760(92)90075-M.","journal-title":"Int J Psychophysiol"},{"issue":"3","key":"1005_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0167-8760(92)90074-L","volume":"13","author":"C Shagass","year":"1992","unstructured":"Shagass C, Roemer RA: Evoked potential topography in major depression. I. Comparisons with nonpatients and schizophrenics. Int J Psychophysiol. 1992, 13 (3): 241-254. 10.1016\/0167-8760(92)90074-L.","journal-title":"Int J Psychophysiol"},{"issue":"3","key":"1005_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000054928","volume":"44","author":"KN Fountoulakis","year":"2001","unstructured":"Fountoulakis KN, Karamouzis M, Iacovides A, Nimatoudis J, Diakogiannis J, Kaprinis G, Demitriadou A, Bech P: Morning and evening plasma melatonin and dexamethasone suppression test in patients with nonseasonal major depressive disorder from northern Greece (latitude 40-41.5 degrees ). Neuropsychobiology. 2001, 44 (3): 113-117. 10.1159\/000054928.","journal-title":"Neuropsychobiology"},{"issue":"3","key":"1005_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0165-1781(89)90207-2","volume":"28","author":"E Souetre","year":"1989","unstructured":"Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, Ardisson JL, Darcourt G: Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res. 1989, 28 (3): 263-278. 10.1016\/0165-1781(89)90207-2.","journal-title":"Psychiatry Res"},{"issue":"2","key":"1005_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/0269881103017002003","volume":"17","author":"GM Goodwin","year":"2003","unstructured":"Goodwin GM: Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003, 17 (2): 149-173. 10.1177\/0269881103017002003. discussion 147","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1005_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0924-977X(00)00140-1","volume":"11","author":"DB Montgomery","year":"2001","unstructured":"Montgomery DB: ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol. 2001, 11 (1): 79-88. 10.1016\/S0924-977X(00)00140-1.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1005_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.v60n0203","volume":"60","author":"J Calabrese","year":"1999","unstructured":"Calabrese J, Rapport D: Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. Journal of Clinical Psychiatry. 1999, 60: 5-13.","journal-title":"Journal of Clinical Psychiatry"},{"key":"1005_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0893-133X(98)00025-6","volume":"19","author":"C Bowden","year":"1998","unstructured":"Bowden C: New concepts in mood stabilization. Neuropsychopharmacology. 1998, 19: 194-199. 10.1016\/S0893-133X(98)00025-6.","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"1005_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.4088\/JCP.v68n1112","volume":"68","author":"P Lemoine","year":"2007","unstructured":"Lemoine P, Guilleminault C, Alvarez E: Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatry. 2007, 68 (11): 1723-1732. 10.4088\/JCP.v68n1112.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1005_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/JCP.0b013e318172b48c","volume":"28","author":"SH Kennedy","year":"2008","unstructured":"Kennedy SH, Rizvi S, Fulton K, Rasmussen J: A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol. 2008, 28 (3): 329-333. 10.1097\/JCP.0b013e318172b48c.","journal-title":"J Clin Psychopharmacol"}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-9-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1744-859X-9-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-9-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:10:46Z","timestamp":1548126646000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/1744-859X-9-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,13]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1186\/1744-859x-9-3","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,13]]},"article-number":"3"}}